Markets:

Overview

News

Currencies

International

Treasuries

Organon & Co. Common Stock (NY:OGN)

6.350 +0.020 (+0.32%)

Official Closing Price Updated: 7:00 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US

November 17, 2025

From Organon & Co.

Via Business Wire

The 5 Most Interesting Analyst Questions From Organon’s Q3 Earnings Call

November 17, 2025

Organon's third quarter was marked by better-than-expected top-line and bottom-line results, which were well received by the market. Management attributed the quarter’s outperformance to strong...

Via StockStory

Topics Earnings

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

November 14, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Organon (OGN) Stock Trades Down, Here Is Why

November 11, 2025

Shares of pharmaceutical company Organon (NYSE:OGN) fell 2.9% in the afternoon session after the company lowered its full-year sales guidance and analysts subsequently cut their price targets on the...

Via StockStory

Topics Artificial Intelligence Initial Public Offering Supply Chain

Organon Analysts Cut Their Forecasts Following Q3 Results ↗

November 11, 2025

Via Benzinga

OGN Q3 2025 Deep Dive: Leadership Changes, Portfolio Shifts, and Guidance Recalibration

November 11, 2025

Pharmaceutical company Organon (NYSE:OGN) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 1.3% year on year to $1.60 billion. On the other hand, the company’s...

Via StockStory

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

A Look at Organon's Upcoming Earnings Report ↗

November 07, 2025

Via Benzinga

Tech Rallies, Palantir Jumps 6% As Shutdown End Looms: What's Moving Markets Monday? ↗

November 10, 2025

Wall Street rebounded on Monday, recovering part of last week's steep losses as investors grew more confident about risk assets amid encouraging signs from Washington that the record-long government...

Via Benzinga

Organon Cuts 2025 Sales Outlook Despite Earnings Beat ↗

November 10, 2025

Organon posts Q3 EPS of $1.01, topping estimates, trims 2025 sales outlook, and highlights positive Vtama data in children with atopic dermatitis.

Via Benzinga

Organon (NYSE:OGN) Posts Better-Than-Expected Sales In Q3

November 10, 2025

Via StockStory

Organon Reports Results for the Third Quarter Ended September 30, 2025

November 10, 2025

From Organon & Co.

Via Business Wire

Organon (OGN) Reports Earnings Tomorrow: What To Expect

November 08, 2025

Pharmaceutical company Organon (NYSE:OGN) will be announcing earnings results this Monday before market hours. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities

November 08, 2025

From Organon & Co.

Via Business Wire

Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie

November 07, 2025

From Organon & Co.

Via Business Wire

Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025

November 06, 2025

From Organon & Co.

Via Business Wire

2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid

November 02, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

1 of Wall Street’s Favorite Stock with Impressive Fundamentals and 2 We Ignore

October 29, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

Why Organon (OGN) Stock Is Down Today

October 28, 2025

Shares of pharmaceutical company Organon (NYSE:OGN) fell 8.9% in the afternoon session after the company announced the resignation of CEO Kevin Ali after an internal investigation uncovered improper...

Via StockStory

Topics Economy Government Initial Public Offering

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

October 28, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Kaplan Fox is Investigating Organon & Co. (OGN) Following an Announcement of Findings of an Audit Committee Investigation and CEO Resignation

October 27, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Kaplan Fox is Investigating Organon & Co. (OGN) Following an Announcement of Findings of an Audit Committee Investigation and CEO Resignation

October 27, 2025

Via TheNewswire.com

Which stocks are moving on Monday? ↗

October 27, 2025

Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Keep an eye on the top gainers and losers in Monday's session. ↗

October 27, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 27, 2025

Via Benzinga

Gold Falls 3%; Carter's Shares Gain After Q3 Earnings ↗

October 27, 2025

Via Benzinga

Which stocks are gapping on Monday? ↗

October 27, 2025

The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

These stocks are moving in today's pre-market session ↗

October 27, 2025

Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Organon CEO Kevin Ali Resigns Amid Audit Probe Into Wholesaler Sales Practices ↗

October 27, 2025

Organon said that the investigation found that certain wholesalers in the United States were asked to buy more Nexplanon than they needed.

Via Stocktwits

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 27, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.